Are subjects satisfied with the informed consent process? A survey of research participants
- PMID: 12672205
Are subjects satisfied with the informed consent process? A survey of research participants
Abstract
Objective: Letters of information (LOI) for clinical trials are becoming longer and more complicated. We investigated patients' perspectives of their ability to understand the information presented during a clinical trial. Satisfaction with and motivation for participation in clinical trials were also ascertained. Perceptions from various treatment disciplines were compared.
Methods: Participants were chosen from 14 clinical trials (departments of rheumatology, ophthalmology, and cardiology) conducted at the same university. Subjects were asked to complete a written questionnaire that assessed demographic information, recall and understanding of information, subjects' decisions to participate, and perceptions/opinions of the study. The response rate was 75% (rheumatology, n = 74; ophthalmology, n = 32; cardiology, n = 84).
Results: The majority of respondents (98%) indicated that they were satisfied with the informed consent process and with their involvement in a trial (97%). Subjects who reported having understood the LOI had better recall of placebo/active drug comparator (p < 0.03), and better understanding of why placebo was used (p < 0.04). No differences were found between those who reported understanding and those who did not on understanding the concept of concealed allocation (blinding). Subjects who felt they had received "the right amount of information" were more likely not to understand concealed allocation. The most frequent reason for trial participation was to help medical science (80%). Subjects with higher education were more likely to understand the reason for placebo use (p < 0.0003), but were not more likely to understand concealed allocation (p < 0.08).
Conclusion: Subjects reported that they were satisfied with the informed consent process and their experience in a clinical trial, and that they understood trial concepts. Subjects may be able to self-assess their own level of understanding for trial concepts that intrinsically make sense within the context of their beliefs about medical care, but other trial concepts may be misunderstood/misinterpreted regardless of self-assessment of understanding or education level (i.e., concealed allocation). Subjects may prefer to believe that investigators know which treatment they are receiving, and have made a good treatment decision specific to their case, despite having being told about concealed allocation and placebo use.
Comment in
-
The experience of trial participation.J Rheumatol. 2003 Apr;30(4):646-7. J Rheumatol. 2003. PMID: 12672179 No abstract available.
Similar articles
-
Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret.Patient Educ Couns. 2006 Oct;63(1-2):104-9. doi: 10.1016/j.pec.2005.09.006. Epub 2005 Oct 19. Patient Educ Couns. 2006. PMID: 16242898
-
Informed consent and participant perceptions of influenza vaccine trials in South Africa.J Med Ethics. 2005 Dec;31(12):727-32. doi: 10.1136/jme.2004.009910. J Med Ethics. 2005. PMID: 16319239 Free PMC article.
-
Who will consent to emergency treatment trials for subarachnoid hemorrhage?Acad Emerg Med. 2009 Apr;16(4):309-15. doi: 10.1111/j.1553-2712.2009.00367.x. Epub 2009 Mar 6. Acad Emerg Med. 2009. PMID: 19298620
-
Clinical trials.Semin Surg Oncol. 1996 Jan-Feb;12(1):32-8. doi: 10.1002/(SICI)1098-2388(199601/02)12:1<32::AID-SSU5>3.0.CO;2-7. Semin Surg Oncol. 1996. PMID: 8821407 Review.
-
The process of clinical trials: a model for successful clinical trial participation.Oncol Nurs Forum. 2001 Aug;28(7):1115-20. Oncol Nurs Forum. 2001. PMID: 11517845 Review.
Cited by
-
The quality of informed consent: mapping the landscape. A review of empirical data from developing and developed countries.J Med Ethics. 2012 Jun;38(6):356-65. doi: 10.1136/medethics-2011-100178. Epub 2012 Feb 7. J Med Ethics. 2012. PMID: 22313664 Free PMC article. Review.
-
Methodological approaches for conducting follow-up research with clinical trial participants: a scoping review and expert interviews.Trials. 2021 Dec 27;22(1):961. doi: 10.1186/s13063-021-05866-6. Trials. 2021. PMID: 34961543 Free PMC article.
-
Informed consent and placebo effects: a content analysis of information leaflets to identify what clinical trial participants are told about placebos.PLoS One. 2012;7(6):e39661. doi: 10.1371/journal.pone.0039661. Epub 2012 Jun 27. PLoS One. 2012. PMID: 22761859 Free PMC article.
-
The reality of informed consent: empirical studies on patient comprehension-systematic review.Trials. 2021 Jan 14;22(1):57. doi: 10.1186/s13063-020-04969-w. Trials. 2021. PMID: 33446265 Free PMC article.
-
Altruism, personal benefit, and anxieties: a phenomenological study of healthy volunteers' experiences in a placebo-controlled trial of duloxetine.Hum Psychopharmacol. 2016 Jul;31(4):332-40. doi: 10.1002/hup.2543. Hum Psychopharmacol. 2016. PMID: 27378326 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources